Triggering the Intrinsic Mitochondrial Death Pathway in Cancer

This direction is merged into another direction: mitochondrial membrane potential assay. Its last version stays readable and citable here.

Version 1 of 121 papers27 conceptsfrozen 2026-10-04

Most cancer therapies aim to force malignant cells into a state of "suicide" known as apoptosis. While cells can be signaled to die from the outside (the extrinsic pathway), aggressive cancers often evolve to ignore these external cues. To bypass this resistance, researchers are increasingly focusing on the intrinsic pathway—a self-destruct sequence initiated from within the cell's own mitochondria.

The Mitochondrial Checkpoint

The mitochondrion is often called the powerhouse of the cell, but in the context of cancer therapy, it acts as a high-security vault containing lethal "executioner" proteins. The integrity of this vault is maintained by the mitochondrial membrane potential (MMP), an electrical gradient across the inner membrane.

When this potential collapses, the vault opens. As Jinxiang Liu and colleagues demonstrated in Emodin induces Panc-1 cell apoptosis via declining the mitochondrial membrane potential, destabilizing the MMP is the "irreversible" step that commits a cell to death. This depolarization acts as a master switch; once the membrane is breached, pro-apoptotic factors leak into the cytoplasm, signaling the end of the cell's life cycle.

The Molecular Tug-of-War

Whether the mitochondrial vault stays closed or opens depends on a delicate balance between two factions of the Bcl-2 protein family: the "protectors" (like Mcl-1 and Bcl-2) and the "executioners" (like Bim, Bax, and Bak).

Cancer cells typically survive by overproducing protectors like Mcl-1 to shield their mitochondria. Modern research focuses on tipping this balance. For instance, Fang Wang showed that Metformin induces apoptosis by microRNA-26a-mediated downregulation of myeloid cell leukaemia-1, effectively stripping away the cancer cell's shield. Similarly, Li Chen found that natural compounds like kaempferol can sensitize resistant liver cancer cells by downregulating Mcl-1, allowing the intrinsic death signal to proceed in Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance.

The Point of No Return: Cytochrome C and Caspases

Once the mitochondrial membrane is compromised, a protein called Cytochrome C escapes into the cytosol. In a healthy cell, Cytochrome C is a vital part of the energy-producing electron transport chain. However, once it enters the main body of the cell, its role changes entirely.

As described by Min Zhou in Ent-Dihydrotucumanoic acid promotes apoptosis in PC-3 human prostate cancer cells, the release of Cytochrome C triggers the assembly of the "apoptosome." This complex activates Caspase-9, which in turn activates Caspase-3. These caspases act as molecular scissors, systematically dismantling the cell’s structural proteins and DNA. This specific sequence—MMP collapse $\rightarrow$ Cytochrome C release $\rightarrow$ Caspase activation—is the hallmark of the intrinsic pathway.

Bypassing Resistance with Caspase-Independent Death

A major challenge in oncology is that some cancers develop mutations that disable the caspase enzymes themselves, making them "immune" to standard apoptosis. To counter this, researchers like Shun X. Ren have explored caspase-independent mechanisms.

In FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells, the authors highlight that mitochondria also house proteins like AIF (Apoptosis-Inducing Factor) and EndoG. When the mitochondria fail, these proteins travel directly to the nucleus to shred DNA without needing caspases. This "backup" system, also observed by Na Yuan using low-dose Bafilomycin A1 in Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia, provides a vital strategy for eliminating the most treatment-resistant malignant cells.

Sensitization and Synergy

The power of the intrinsic pathway lies not just in its ability to kill cells directly, but in its ability to make other treatments more effective. By lowering the "threshold" for mitochondrial collapse, compounds can act as sensitizers.

For example, Da‐Young Eum demonstrated that the compound AM-18002 increases the "radiosensitivity" of breast cancer cells by pre-weakening their mitochondrial defenses in AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells. Similarly, Jiawei Guan showed that inducing DNA breaks with triptolide can prime the caspase cascade, making B-cell lymphoma cells significantly more vulnerable to other targeted inhibitors in Triptolide induces DNA breaks, activates caspase-3-dependent apoptosis and sensitizes B-cell lymphoma.

By targeting the mitochondria, these diverse therapeutic approaches converge on a single, vulnerable bottleneck in cancer cell survival, offering a way to force even the most aggressive tumors into a programmed retreat.

Papers in this version

History & citationVersion 1 · 2026-10-04

Merged into another direction · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_triggering_the_intrinsic_mitochondrial_d_cb255306,
  title = {Triggering the Intrinsic Mitochondrial Death Pathway in Cancer},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/triggering-the-intrinsic-mitochondrial-death-pathway-in-cancer/rdr_cb255306b0a5485da8f62455559d9dc5},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_triggering_the_intrinsic_mitochondrial_d_cb255306_v1,
  title = {Triggering the Intrinsic Mitochondrial Death Pathway in Cancer},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/triggering-the-intrinsic-mitochondrial-death-pathway-in-cancer/rdr_cb255306b0a5485da8f62455559d9dc5/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}